XCellCure Company
XCellCure is a BIPOC woman founded biotechnology company with exciting, award winning CVD diagnostic/prognostic technology focused on transforming modern cardiac care by enabling quantitative, low-cost prevention. With the launch of their first product, the AMiAware Human Cardiovascular Disease Microarray, the product line aids the prevention of recurrent heart attack through patient-centered risk stratification utilizing 13 novel biomarkers.
Industry:
Longevity
Headquarters:
St Louis, Missouri, United States
Founded Date:
23-11-2010
Employees Number:
1-10
Estimated Revenue:
$1M to $10M
Register and Claim Ownership